Stefania Mosconi

4.6k total citations · 1 hit paper
40 papers, 2.3k citations indexed

About

Stefania Mosconi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stefania Mosconi has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Stefania Mosconi's work include Colorectal Cancer Treatments and Studies (18 papers), Colorectal Cancer Surgical Treatments (9 papers) and Genetic factors in colorectal cancer (8 papers). Stefania Mosconi is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Colorectal Cancer Surgical Treatments (9 papers) and Genetic factors in colorectal cancer (8 papers). Stefania Mosconi collaborates with scholars based in Italy, Germany and Spain. Stefania Mosconi's co-authors include Roberto Labianca, Giordano Beretta, Mario Mandalà, Bernard Nordlinger, Andrés Cervantes, Dirk Arnold, Gemma Gatta, Laura Milesi, M.A. Pessi and Antonello Quadri and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Stefania Mosconi

38 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2013 1.1k citations Roberto Labianca, Giordano Beretta et al. Annals of Oncology profile →

Peers

Stefania Mosconi

ONCOL

SURGE

PRM

PFM

Vincenzo Formica Italy

Mary Cabiddu Italy

Diego Cortinovis Italy

Şuayib Yalçın Türkiye

Jeng‐Fu You Taiwan

Reiping Tang Taiwan

D. Machover France

Stéphane Éderhy France

Junshik Hong South Korea

Giovanni Luca Frassineti Italy

Vincenzo Formica Italy

Stefania Mosconi

1.1k ×0.7

ONCOL

299 ×0.4

SURGE

356 ×0.5

PRM

179 ×0.4

PFM

293 ×0.7

Citations per year, relative to Stefania Mosconi Stefania Mosconi (= 1×) peers Vincenzo Formica

Countries citing papers authored by Stefania Mosconi

Since Specialization

Citations

This map shows the geographic impact of Stefania Mosconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Mosconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Mosconi more than expected).

Fields of papers citing papers by Stefania Mosconi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Mosconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Mosconi. The network helps show where Stefania Mosconi may publish in the future.

Co-authorship network of co-authors of Stefania Mosconi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Mosconi. A scholar is included among the top collaborators of Stefania Mosconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Mosconi. Stefania Mosconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zampino, Maria Giulia, Stefania Mosconi, Marianna Alessandra Gerardi, et al.. (2024). 509O Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial. Annals of Oncology. 35. S431–S432. 6 indexed citations

Siena, Salvatore, Alessio Amatu, Katia Bencardino, et al.. (2023). Total neoadjuvant treatment without surgery for locally advanced rectal cancer: Prospective study to assess tumor response, circulating genetic, and epigenetic biomarkers, and stromal transcriptome to interpret clinical outcome (NO-CUT trial).. Journal of Clinical Oncology. 41(16_suppl). TPS3633–TPS3633. 2 indexed citations

Allievi, Niccolò, Federica Bianco, Michele Pisano, et al.. (2022). Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Updates in Surgery. 75(1). 159–167. 9 indexed citations

Rosati, Gerardo, Chiara Alessandra Cella, Luigi Cavanna, et al.. (2022). A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial. Gastric Cancer. 25(4). 783–793. 4 indexed citations

Zambelli, Alberto, Vittoria Fotia, Paola Poletti, et al.. (2020). 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy. Annals of Oncology. 31. S994–S994. 5 indexed citations

Cascinu, Stefano, Rossana Berardi, Roberto Bianco, et al.. (2019). Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial. Annals of Oncology. 30. v253–v254. 4 indexed citations

Reni, Michele, Gianpaolo Balzano, Silvia Zanon, et al.. (2018). Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial. The Lancet. Gastroenterology & hepatology. 3(6). 413–423. 166 indexed citations

Reni, Michele, Silvia Zanon, Gianpaolo Balzano, et al.. (2017). Randomized phase 2 trial of peri- or post-operative chemotherapy in resectable pancreatic adenocarcinoma. Annals of Oncology. 28. vi44–vi44. 1 indexed citations

Cereda, Stefano, Michèle Milella, Stefano Cordio, et al.. (2015). Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma. Cancer Chemotherapy and Pharmacology. 77(1). 109–114. 12 indexed citations

10.

Gasparini, Giampietro, Fiamma Buttitta, Mario D’Andrea, et al.. (2014). Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer. Neoplasia. 16(9). 751–756. 3 indexed citations

11.

Cascinu, Stefano, Rossana Berardi, Alberto F. Sobrero, et al.. (2013). Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study. Digestive and Liver Disease. 46(2). 182–186. 41 indexed citations

12.

Labianca, Roberto, Barbara Merelli, & Stefania Mosconi. (2012). Treatment of advanced pancreatic cancer. Annals of Oncology. 23. x139–x140. 6 indexed citations

13.

Labianca, Roberto, Giordano Beretta, Laura Milesi, et al.. (2010). Colon cancer. Critical Reviews in Oncology/Hematology. 74(2). 106–133. 308 indexed citations

14.

Mandalà, Mario, Sandro Barni, Irene Floriani, et al.. (2008). Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings. European Journal of Cancer. 45(1). 65–73. 46 indexed citations

15.

Mandalà, Mario, Michele Reni, Stefano Cascinu, et al.. (2007). Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Annals of Oncology. 18(10). 1660–1665. 113 indexed citations

16.

Labianca, Roberto, Laura Milesi, Stefania Mosconi, et al.. (2007). The role of adjuvant chemotherapy in colon cancer. Surgical Oncology. 16. 93–96. 10 indexed citations

17.

Labianca, Roberto, Stefania Mosconi, & Marina Chiara Garassino. (2006). New strategies in colon cancer adjuvant therapy. Annals of Oncology. 17. vii51–vii54. 5 indexed citations

18.

Labianca, Roberto, Giordano Beretta, Stefania Mosconi, Laura Milesi, & M.A. Pessi. (2005). Colorectal cancer: screening. Annals of Oncology. 16. ii127–ii132. 23 indexed citations

19.

Graziano, Francesco, Daniele Santini, E. Testa, et al.. (2003). A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. British Journal of Cancer. 89(8). 1428–1432. 17 indexed citations

20.

Mosconi, Stefania. (2002). H. Bleiberg, N. Kemeny, P. Rougier, H. Wilke (eds). Colorectal Cancer: a Clinical Guide to Therapy. Annals of Oncology. 13(12). 1957–1957. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact